To assess change in intraocular pressure ( IOP ) in patients with neovascular age-related macular degeneration ( NVAMD ) receiving intravitreal aflibercept injection ( IAI ) or ranibizumab in VEGF Trap-Eye : Investigation of Efficacy and Safety in Wet AMD ( VIEW ) 1 and 2 studies .